CARLSBAD, Calif. and MUNICH, Oct. 26, 2015 /PRNewswire/ -- BIO-Europe® 2015 international life science partnering conference, held in Munich, Germany, November 2–4, 2015, expects over 3,300 delegates representing investors, biotech innovators and pharmaceutical executives from the global drug development industry.
"BIO-Europe is a valuable forum for us to meet a wide range of companies," said Jeremy Springhorn, PhD, Partner, Corporate Development at Flagship Ventures. "We understand the importance of strategic partnerships, and BIO-Europe continues to be a productive event for building relationships."
"At Bristol-Myers Squibb, we have long since recognized that innovation happens everywhere and partnering has been an important part of our strategy for decades," said Mohamed Ragab, VP Oncology Search and Evaluation, Bristol-Myers Squibb. "We are always in search of partners who can help us continue to advance the science of immuno-oncology, and BIO-Europe enables us to evaluate a large number of companies and potential licensing opportunities in a short amount of time."
Another big draw of BIO-Europe 2015 will be the high-caliber presenting companies attending. Over 150 biotech, midsize pharma, next generation and academic-phase companies are expected to present and an estimated 4,000 licensing opportunities will be on offer at the event.
Leading pharmaceutical companies sponsoring the event send teams of scouts to BIO-Europe to engage with new and innovative products, ideas and companies. Large drug development firms in attendance and ready to partner include:
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Johnson & Johnson
- Novo Nordisk
- Takeda, and more.
BIO-Europe registration numbers are already up and expected to surpass last year's edition. The 2014 event featured 17,902 one-to-one partnering meetings. Over 3,200 delegates from 1,772 companies representing 54 countries attended. There were 162 company presentations with 4,032 licensing opportunities on offer, and 98 exhibitors at the event.
BIO-Europe registration information is available online.
Additional links and information:
Follow BIO-Europe 2015 on Twitter: @EBDGroup (hashtag: #BEU15).
Online Press Kit service for BIO-Europe 2015 is available from PR Newswire to enhance your public relations efforts.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group's conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe's largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® Group
- Biolatam®, facilitating partnering among global life sciences executives in Latin America's vibrant life science hubs
EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
SOURCE EBD Group